Qaca Igg/Igm Elisa Kit
510(k) K020241
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK020241 | Date13 Mar 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MID
- FDA applicant
- Cheshire Diagnostics , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5660
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The QACA IgG/IgM ELISA Kit is an in vitro immunoassay for the semi-quantitative detection of IgG and IgM antibodies to cardiolipin in human serum. Classified as a Test, Anticardiolipin Immunological device, it is designed to facilitate immunological testing within the field of immunology. This kit employs the Enzyme-Linked Immunosorbent Assay (ELISA) method to measure antibody levels, aiding in the assessment of antiphospholipid syndrome markers.
This kit is intended for use in clinical laboratory settings and is supplied as a single-use diagnostic tool. It is not sterile and requires preparation according to the provided instructions. The device is regulated under FDA 510(k) clearance (K020241) and falls under Class II medical devices, adhering to regulatory standards for immunological testing. No specific MRI safety information or storage conditions are provided in the data.
Other devices from Cheshire Diagnostics, Ltd.
Questions
AI-generated answers, 1 Oct 2026
What is the QACA IgG/IgM ELISA Kit used for?
This kit is designed for the semi-quantitative detection of IgG and IgM antibodies to cardiolipin in human serum. It helps assess markers associated with antiphospholipid syndrome, a condition linked to autoimmune-related blood clotting disorders. The ELISA method measures antibody levels, providing clinical insights for immunology testing.
Is the QACA IgG/IgM ELISA Kit sterile?
No, the QACA IgG/IgM ELISA Kit is not sterile. It is supplied as a single-use diagnostic tool and requires preparation according to the included instructions before use. Sterility is not a feature of this device, as it is intended for laboratory use where aseptic technique is applied during testing.
How is the QACA IgG/IgM ELISA Kit supplied?
The kit is supplied as a single-use diagnostic tool, meaning each kit is intended for one testing procedure. It does not require sterilization before use, but proper handling and preparation as outlined in the instructions are necessary to ensure accurate results. The kit is designed for clinical laboratory settings.
What regulatory clearance does the QACA IgG/IgM ELISA Kit hold?
The QACA IgG/IgM ELISA Kit holds FDA 510(k) clearance under the reference number K020241. This clearance indicates that the device has been deemed substantially equivalent to a legally marketed predicate device and adheres to regulatory standards for immunological testing. It is classified as a Class II medical device.
Are there specific storage conditions mentioned for the QACA IgG/IgM ELISA Kit?
The provided data does not specify any particular storage conditions for the QACA IgG/IgM ELISA Kit. Users should follow general laboratory practices for storing diagnostic reagents, typically involving protection from extreme temperatures, light, and contamination. Always refer to the included instructions for any additional guidance.